Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E24.53 EPS (ttm)1.49 Insider Own0.05% Shs Outstand5.56B Perf Week-1.83%
Market Cap203.22B Forward P/E11.77 EPS next Y3.10 Insider Trans-5.99% Shs Float5.55B Perf Month-4.02%
Income8.36B PEG- EPS next Q0.52 Inst Own69.90% Short Float1.18% Perf Quarter1.89%
Sales48.65B P/S4.18 EPS this Y62.30% Inst Trans-0.16% Short Ratio1.40 Perf Half Y4.97%
Book/sh11.74 P/B3.11 EPS next Y8.58% ROA5.00% Target Price41.79 Perf Year-4.52%
Cash/sh1.89 P/C19.36 EPS next 5Y-1.00% ROE13.50% 52W Range26.42 - 43.08 Perf YTD-0.84%
Dividend1.56 P/FCF97.23 EPS past 5Y14.70% ROI14.70% 52W High-15.27% Beta0.68
Dividend %4.27% Quick Ratio1.10 Sales past 5Y0.90% Gross Margin80.10% 52W Low38.14% ATR0.71
Employees88300 Current Ratio1.40 Sales Q/Q-4.30% Oper. Margin13.30% RSI (14)41.49 Volatility1.09% 1.60%
OptionableYes Debt/Eq0.97 EPS Q/Q-71.30% Profit Margin17.90% Rel Volume0.76 Prev Close36.73
ShortableYes LT Debt/Eq0.76 EarningsFeb 02 BMO Payout95.80% Avg Volume46.58M Price36.50
Recom2.70 SMA20-1.48% SMA50-2.99% SMA2003.24% Volume35,264,205 Change-0.63%
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jan-20-21 06:14PM  
05:45PM  
04:13PM  
03:05PM  
01:43PM  
01:32PM  
11:56AM  
11:11AM  
10:46AM  
09:25AM  
09:05AM  
08:26AM  
07:51AM  
07:48AM  
07:12AM  
06:01AM  
04:58AM  
02:56AM  
Jan-19-21 03:56PM  
02:00PM  
01:57PM  
01:57PM  
01:25PM  
01:15PM  
01:14PM  
11:44AM  
09:49AM  
08:53AM  
08:05AM  
07:46AM  
07:15AM  
05:31AM  
Jan-18-21 11:02PM  
10:02PM  
03:55PM  
01:09PM  
12:52PM  
11:34AM  
10:05AM  
09:05AM  
08:46AM  
06:07AM  
05:59AM  
05:42AM  
04:24AM  
02:58AM  
Jan-17-21 04:53PM  
07:02AM  
Jan-16-21 02:55AM  
Jan-15-21 03:35PM  
02:39PM  
02:37PM  
01:46PM  
12:56PM  
11:23AM  
10:55AM  
10:51AM  
10:20AM  
10:11AM  
09:55AM  
09:46AM  
09:43AM  
08:24AM  
07:30AM  
06:11AM  
Jan-14-21 04:55PM  
04:30PM  
04:17PM  
03:31PM  
02:36PM  
12:16PM  
12:10PM  
11:44AM  
08:09AM  
Jan-13-21 05:45PM  
05:44PM  
03:41PM  
02:29PM  
01:53PM  
01:02PM  
12:48PM  
10:39AM  
10:08AM  
09:57AM  
05:45AM  
05:22AM  
Jan-12-21 08:06PM  
05:45PM  
04:56PM  
04:29PM  
02:30PM  
01:40PM  
01:16PM  
01:02PM  
11:30AM  
11:28AM  
11:26AM  
10:54AM  
10:37AM  
10:22AM  
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Myovant Sciences Ltd.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; a drug discovery collaboration with Sosei Group Corporation; and collaboration with LianBio. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5513,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM
GOETTLER MICHAELGroup PresidentFeb 28Option Exercise27.3722,852625,45953,036Mar 03 12:54 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3715,996437,81187,956Mar 03 12:54 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3738,8481,063,270172,542Mar 03 12:54 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 28Option Exercise27.3737,9341,038,254140,256Mar 03 12:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 28Option Exercise27.3717,824487,84330,045Mar 03 12:54 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.3791,4082,501,837222,496Mar 03 12:55 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37100,5482,751,999504,427Mar 03 12:55 PM
BOURLA ALBERTChairman & CEOFeb 28Option Exercise27.3733,135906,905232,888Mar 03 12:49 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3727,422750,540140,744Mar 03 12:49 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37173,6754,753,485556,084Mar 03 12:49 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise34.59144,9285,013,060503,738Feb 28 07:32 PM
ROGERS DAWNExecutive Vice PresidentFeb 26Option Exercise34.5915,097522,20524,995Feb 28 07:28 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise34.5972,4642,506,530180,558Feb 28 07:28 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise34.5933,4141,155,79093,211Feb 28 07:24 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise34.5988,5673,063,533189,936Feb 28 07:25 PM
GOETTLER MICHAELGroup PresidentFeb 26Option Exercise34.5920,129696,26245,557Feb 28 07:22 PM
Hwang AngelaGroup PresidentFeb 26Option Exercise34.5914,493501,31332,470Feb 28 07:22 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise34.59144,9285,013,060482,320Feb 28 07:19 PM
BOURLA ALBERTChairman & CEOFeb 26Option Exercise34.5988,5673,063,533274,479Feb 28 07:16 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise34.5924,155835,521131,196Feb 28 07:15 PM
Gottlieb ScottDirectorJan 30Buy37.001,00036,9974,000Jan 31 08:06 AM